Skip to main content
Top
Published in: International Urology and Nephrology 2/2016

01-02-2016 | Nephrology - Original article

Hemodiafiltration and hemodialysis differently affect P wave duration and dispersion on the surface electrocardiogram

Authors: Alida Páll, Árpád Czifra, Veronika Sebestyén, Gergely Becs, Csaba Kun, József Balla, György Paragh, István Lőrincz, Dénes Páll, Tamás János Padra, Anupam Agarwal, Abolfazl Zarjou, Zoltán Szabó

Published in: International Urology and Nephrology | Issue 2/2016

Login to get access

Abstract

Aim

The incidence of atrial fibrillation is increased during hemodialysis (HD); however, the effects of hemodiafiltration (HDF) on atrial arrhythmias have not been evaluated. The prolongation of the P wave and P dispersion (Pd) can predict atrial arrhythmias.

Methods

Data from 30 patients receiving HDF over a period of 3 months were collected; the same group of patients was then evaluated during treatment with conventional HD for at least another 3 months. Electrolyte values were obtained, and surface electrocardiograms (ECG), echocardiography, and Holter ECGs were performed.

Results

The duration of the P wave and Pd increased significantly during HD. The left atrial diameter decreased significantly only during HDF. During HDF, the left atrial cross diameter measured at the beginning of the session was positively correlated with the incidence of supraventricular premature beats (p = 0.011, r = 0.4556). The decrease in left atrial diameter during HDF was negatively correlated with the incidence of supraventricular premature beats (p = 0.016, r = −0.43). During HDF, the changes in sodium and Pd were significantly positively correlated (p < 0.05, r = 0.478). During HD, the changes in ionized calcium levels and Pd were positively correlated (p < 0.05, r = 0.377).

Conclusion

Our results suggest that HDF has a more beneficial effect on P wave duration and Pd than HD. The alterations in the ECG markers may be the result of the simultaneous occurrence of certain electrolyte imbalances and renal replacement methods.
Literature
1.
go back to reference McCullough PA, Steigerwalt S, Tolia K et al (2011) Cardiovascular disease in chronic kidney disease: data from the Kidney Early Evaluation Program (KEEP). Curr Diab Rep 11(1):47–55PubMedPubMedCentralCrossRef McCullough PA, Steigerwalt S, Tolia K et al (2011) Cardiovascular disease in chronic kidney disease: data from the Kidney Early Evaluation Program (KEEP). Curr Diab Rep 11(1):47–55PubMedPubMedCentralCrossRef
2.
go back to reference Meier P, Vogt P, Blanc E (2001) Ventricular arrhythmias and sudden cardiac death in end-stage renal disease patients on chronic hemodialysis. Nephron 87(3):199–214PubMedCrossRef Meier P, Vogt P, Blanc E (2001) Ventricular arrhythmias and sudden cardiac death in end-stage renal disease patients on chronic hemodialysis. Nephron 87(3):199–214PubMedCrossRef
3.
go back to reference Abe S, Yoshizawa M, Nakanishi N et al (1996) Electrocardiographic abnormalities in patients receiving hemodialysis. Am Heart J 131(6):1137–1144PubMedCrossRef Abe S, Yoshizawa M, Nakanishi N et al (1996) Electrocardiographic abnormalities in patients receiving hemodialysis. Am Heart J 131(6):1137–1144PubMedCrossRef
4.
go back to reference Dittrich HC, Pearce LA, Asinger RW et al (1999) Left atrial diameter in nonvalvular atrial fibrillation: an echocardiographic study. Stroke Prevention in Atrial Fibrillation Investigators. Am Heart J 137(3):494–499PubMedCrossRef Dittrich HC, Pearce LA, Asinger RW et al (1999) Left atrial diameter in nonvalvular atrial fibrillation: an echocardiographic study. Stroke Prevention in Atrial Fibrillation Investigators. Am Heart J 137(3):494–499PubMedCrossRef
5.
go back to reference Shapira OM, Bar-Khayim Y (1992) ECG changes and cardiac arrhythmias in chronic renal failure patients on hemodialysis. J Electrocardiol 25(4):273–279PubMedCrossRef Shapira OM, Bar-Khayim Y (1992) ECG changes and cardiac arrhythmias in chronic renal failure patients on hemodialysis. J Electrocardiol 25(4):273–279PubMedCrossRef
6.
go back to reference Genovesi S, Vincenti A, Rossi E et al (2008) Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients. Am J Kidney Dis 51(2):255–262PubMedCrossRef Genovesi S, Vincenti A, Rossi E et al (2008) Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients. Am J Kidney Dis 51(2):255–262PubMedCrossRef
7.
go back to reference Vanholder R, Meert N, Schepers E et al (2008) From uremic toxin retention to removal by convection: do we know enough? Contrib Nephrol 161:125–131PubMedCrossRef Vanholder R, Meert N, Schepers E et al (2008) From uremic toxin retention to removal by convection: do we know enough? Contrib Nephrol 161:125–131PubMedCrossRef
8.
go back to reference Locatelli F, Marcelli D, Conte F et al (1999) Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. The Registro Lombardo Dialisi E Trapianto. Kidney Int 55(1):286–293PubMedCrossRef Locatelli F, Marcelli D, Conte F et al (1999) Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. The Registro Lombardo Dialisi E Trapianto. Kidney Int 55(1):286–293PubMedCrossRef
9.
go back to reference Shimada K, Tomita T, Kamijo Y et al (2012) Hemodialysis-induced P-wave signal-averaged electrocardiogram alterations are indicative of vulnerability to atrial arrhythmias. Circ J 76(3):612–617PubMedCrossRef Shimada K, Tomita T, Kamijo Y et al (2012) Hemodialysis-induced P-wave signal-averaged electrocardiogram alterations are indicative of vulnerability to atrial arrhythmias. Circ J 76(3):612–617PubMedCrossRef
10.
go back to reference Andrikopoulos GK, Dilaveris PE, Richter DJ et al (2000) Increased variance of P wave duration on the electrocardiogram distinguishes patients with idiopathic paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 23(7):1127–1132PubMedCrossRef Andrikopoulos GK, Dilaveris PE, Richter DJ et al (2000) Increased variance of P wave duration on the electrocardiogram distinguishes patients with idiopathic paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 23(7):1127–1132PubMedCrossRef
11.
go back to reference Aytemir K, Ozer N, Atalar E et al (2000) P wave dispersion on 12-lead electrocardiography in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 23(7):1109–1112PubMedCrossRef Aytemir K, Ozer N, Atalar E et al (2000) P wave dispersion on 12-lead electrocardiography in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 23(7):1109–1112PubMedCrossRef
12.
go back to reference Dilaveris PE, Gialafos EJ, Sideris SK et al (1998) Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 135(5 Pt 1):733–738PubMedCrossRef Dilaveris PE, Gialafos EJ, Sideris SK et al (1998) Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 135(5 Pt 1):733–738PubMedCrossRef
13.
go back to reference Szabó Z, Kakuk G, Fülöp T et al (2002) Effects of haemodialysis on maximum P wave duration and P wave dispersion. Nephrol Dial Transplant 17(9):1634–1638PubMedCrossRef Szabó Z, Kakuk G, Fülöp T et al (2002) Effects of haemodialysis on maximum P wave duration and P wave dispersion. Nephrol Dial Transplant 17(9):1634–1638PubMedCrossRef
14.
go back to reference Canaud B, Bragg-Gresham JL, Marshall MR et al (2006) Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int 69(11):2087–2093PubMedCrossRef Canaud B, Bragg-Gresham JL, Marshall MR et al (2006) Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int 69(11):2087–2093PubMedCrossRef
15.
go back to reference Francisco RC, Aloha M, Ramon PS (2012) Effects of high-efficiency postdilution online hemodiafiltration and high-flux hemodialysis on serum phosphorus and cardiac structure and function in patients with end-stage renal disease. Int Urol Nephrol 45(5):1373–1378PubMedCrossRef Francisco RC, Aloha M, Ramon PS (2012) Effects of high-efficiency postdilution online hemodiafiltration and high-flux hemodialysis on serum phosphorus and cardiac structure and function in patients with end-stage renal disease. Int Urol Nephrol 45(5):1373–1378PubMedCrossRef
16.
go back to reference Mostovaya IM, Blankestijn PJ (2013) What have we learned from CONTRAST? Blood Purif 35(Suppl):1 Mostovaya IM, Blankestijn PJ (2013) What have we learned from CONTRAST? Blood Purif 35(Suppl):1
17.
go back to reference Kerr PB, Argiles A, Flavier JL et al (1992) Comparison of hemodialysis and hemodiafiltration: a long-term longitudinal study. Kidney Int 41(4):1035–1040PubMedCrossRef Kerr PB, Argiles A, Flavier JL et al (1992) Comparison of hemodialysis and hemodiafiltration: a long-term longitudinal study. Kidney Int 41(4):1035–1040PubMedCrossRef
18.
go back to reference Panichi V, Paoletti S, Consani C (2008) Inflammatory pattern in hemodiafiltration. Contrib Nephrol 161:185–190PubMedCrossRef Panichi V, Paoletti S, Consani C (2008) Inflammatory pattern in hemodiafiltration. Contrib Nephrol 161:185–190PubMedCrossRef
19.
go back to reference van Tellingen A, Grooteman MP, Schoorl M et al (2002) Intercurrent clinical events are predictive of plasma C-reactive protein levels in hemodialysis patients. Kidney Int 62(2):632–638PubMedCrossRef van Tellingen A, Grooteman MP, Schoorl M et al (2002) Intercurrent clinical events are predictive of plasma C-reactive protein levels in hemodialysis patients. Kidney Int 62(2):632–638PubMedCrossRef
20.
go back to reference Blankestijn PJ, Vos PF, Rabelink TJ et al (1995) High-flux dialysis membranes improve lipid profile in chronic hemodialysis patients. J Am Soc Nephrol 5(9):1703–1708PubMed Blankestijn PJ, Vos PF, Rabelink TJ et al (1995) High-flux dialysis membranes improve lipid profile in chronic hemodialysis patients. J Am Soc Nephrol 5(9):1703–1708PubMed
21.
go back to reference Bonforte G, Grillo P, Zerbi S et al (2002) Improvement of anemia in hemodialysis patients treated by hemodiafiltration with high-volume on-line-prepared substitution fluid. Blood Purif 20(4):357–363PubMedCrossRef Bonforte G, Grillo P, Zerbi S et al (2002) Improvement of anemia in hemodialysis patients treated by hemodiafiltration with high-volume on-line-prepared substitution fluid. Blood Purif 20(4):357–363PubMedCrossRef
22.
go back to reference Ohtake T, Oka M, Ishioka K et al (2012) Cardiovascular protective effects of on-line hemodiafiltration: comparison with conventional hemodialysis. Ther Apher Dial 16(2):181–188PubMedCrossRef Ohtake T, Oka M, Ishioka K et al (2012) Cardiovascular protective effects of on-line hemodiafiltration: comparison with conventional hemodialysis. Ther Apher Dial 16(2):181–188PubMedCrossRef
23.
go back to reference Ok E, Asci G, Toz H et al (2013) Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study. Nephrol Dial Transplant 28(1):192–202PubMedCrossRef Ok E, Asci G, Toz H et al (2013) Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study. Nephrol Dial Transplant 28(1):192–202PubMedCrossRef
24.
go back to reference Barta K, Czifra Á, Kun C et al (2014) Hemodiafiltration beneficially affects QT interval duration and dispersion compared to hemodialysis. Clin Exp Nephrol 18(6):952–959PubMedCrossRef Barta K, Czifra Á, Kun C et al (2014) Hemodiafiltration beneficially affects QT interval duration and dispersion compared to hemodialysis. Clin Exp Nephrol 18(6):952–959PubMedCrossRef
Metadata
Title
Hemodiafiltration and hemodialysis differently affect P wave duration and dispersion on the surface electrocardiogram
Authors
Alida Páll
Árpád Czifra
Veronika Sebestyén
Gergely Becs
Csaba Kun
József Balla
György Paragh
István Lőrincz
Dénes Páll
Tamás János Padra
Anupam Agarwal
Abolfazl Zarjou
Zoltán Szabó
Publication date
01-02-2016
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 2/2016
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-015-1144-4

Other articles of this Issue 2/2016

International Urology and Nephrology 2/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine